Aviva has overhauled its cancer coverage for both individual and group private medical insurance (PMI) schemes.
Its new regime includes the removal of previous benefit limits for some cancer drugs, bone related treatments and scans and rehabilitation. The provider has also pledged to cover cancer treatments recommended by medical specialists in full, while following cancer treatment, aftercare benefits including consultations with dieticians and help with the costs of wigs and external prostheses are included. Treatment cover now includes chemotherapy, radiotherapy and targeted therapies such as Herceptin and Avastin, as well as cover for unlicensed drugs not readily available from the NHS. ...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
